Steven M. Horwitz, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses some new treatments on the horizon for T-cell lymphoma.
Pediatric patients with ALL can expect therapies to help target their disease after they relapse, but experts are looking to combat the disease in the frontline before that.
Sheila Hunt, RN, Baylor Scott and White McClinton Cancer Center, discusses how she manages day-to-day stress as an oncology nurse.
Dorothy N. Pierce, APN-C, RN, Rutgers Cancer Institute of New Jersey, provides an overview of advanced practice nurse care in radiation oncology.
For clinical nurse specialist and Oncology Nursing Society (ONS) member Anne Kolenic, DNP, APRN, AOCNS, her decision to pursue a DNP degree meant taking critical research results and implementing them to improve care at her institution.
Patients with CLL prescribed BTK inhibitors may have a higher chance of developing secondary cancers, according to recent research.
Mary Gullatte, president of the Oncology Nursing Society, explains the impact that oncology nurses have on the lives of both patients and their families.
Adolescents and young adults (AYAs) with cancer diagnosed between the ages of 15 and 39 are a unique group of patients with distinct cancer epidemiology and developmental characteristics.
Three oncology nurses at the Smilow Cancer Hospital at Yale-New Haven write about the Smilow Society, an interactive and innovative journal club enabling nurses to stay abreast of important research developments, which can then be translated directly into clinical practice.
Patients on active therapy during the coronavirus disease 2019 (COVID-19) pandemic, as well as oncology care providers, have increased levels of perceived and posttraumatic stress, according to preliminary data from the COVIPACT study. These data highlight a gap in psychosocial support resources that help promote emotional resilience and reduce the risk of posttraumatic stress in patients on active therapy.
Gwendolyn Quinn, PhD, discusses the importance of educating nurses and physicians about reproductive health.
Amanda Bontempo, MS, RD, CSO, CDN, gives some tips for healthy eating. Join us on 4/18 at 1 PM for our tweetchat, with Bontempo as moderator, to discuss more nutrition.
The ACCC created the Immuno-Oncology Institute to help community practices address up-and-coming questions around immunotherapy implementation.
The FDA has granted a priority review designation to a supplemental new drug application for enzalutamide (Xtandi) for the treatment of men with metastatic hormone-sensitive prostate cancer (mHSPC), according to Astellas Pharma Inc. and Pfizer Inc., the codevelopers of the androgen receptor inhibitor.
Dellann Elliott Mydland, from the Chris Elliott Fund, discusses the importance of testing brain tumor tissue before surgery.
Dawn Hershman, MD, MS, medical oncologist, Columbia University Medical Center, discusses the HOPE Study, a randomized trial of exercise vs. usual care on aromatase inhibitor-associated arthralgias in women with breast cancer.
Now more than ever, it is important for new nurses to keep their head up and ensure that their voice is heard, according to Theresa Brown, RN.
Real-world data demonstrate significant outcome improvements with enfortumab vedotin in patients with unresectable or metastatic urothelial carcinoma.
The pandemic may elicit fear, but nurses’ dedication to their patients remains steadfast.
Lee Greenberger, PhD, chief scientific officer, The Leukemia & Lymphoma Society, discusses new agents that were recently approved for multiple myeloma.
Find ways to bring up these topics in patient conversations, while mitigating feelings of shame.
The patient's daughter had not been at the initial consult and thus had only secondhand information from her father and mother.
How patients can be their own advocates and maximize their care team appointments by speaking up and asking questions.
Nurses can take part in turning the tide against the disease.
With additional JAK inhibitors under exploration in the myelofibrosis pipeline, such as momelotinib and pacritinib, FDA-approved options continue to be utilized heavily in the paradigm, explained John O. Mascarenhas, MD.
Linda Grush, Illinois chapter president, Debbie's Dream Foundation, explains what happens when a patient with stomach cancer reaches out to the foundation for more information.
Performing frequent assessments and assisting with hygiene is vital to preserving and improving quality of life.
Each type of cancer treatment has its own adverse event (AE) profile, and BRAF and MEK inhibitors are no different.
A job in oncology nursing is both stressful and rewarding—whether you have been working in the profession for 10 days or 10 years. We recently asked our readers and cancer survivors what advice they would give to new oncology nurses. What follows is just some of the advice shared.
Carmela Hoefling, RN, MSN, APN-C, AOCNP, Rutgers Cancer Institue of New Jersey, discusses what oncology nurses can do to identify and treat patients who may be malnourished.